West Health’s CEO Shelley Lyford participated in a panel at the Fifth International Vatican Conference titled: Quelling the Quandary of Drug and Therapy Affordability for Chronic Diseases. The discussion centered on moving toward a more value-based pricing system for prescription drugs while still fostering innovation. Also, the panel explored the market failures of drug pricing and the solutions that can help patients access affordable drugs that improve the quality of their lives.
Aaron J. Kowalski, PhD, President and CEO, JDRF International
Dan Liljenquist, Senior Vice President and Chief Strategy Officer, Intermountain Healthcare
Shelley Lyford, President and CEO, Gary and Mary West Foundation
Moderator: Mark McClellan, MD, PhD, Director, Duke-Robert J. Margolis, MD, Center for Health Policy and Robert J. Margolis, MD, Professor of Business, Medicine, and Policy, Duke University
The Fifth International Vatican Conference and all related materials were made possible through the leadership and support of the Cura Foundation, the Vatican’s Pontifical Council for Culture, and all of the supporters, sponsors and grantors, as well as their affiliates, including The Leona M. and Harry B. Helmsley Charitable Trust and the John Templeton Foundation. The opinions expressed during the sessions, interviews and other conference and related events are those of the speakers, participants and/or any other individuals do not necessarily reflect the views of the Cura Foundation, the Vatican’s Pontifical Council for Culture, and/or the supporters, sponsors and grantors.